文献速递外周动脉疾病

肱动脉真性动脉瘤的表现、治疗与结局

Presentation, treatment, and outcomes of brachial artery aneurysms.
PubMed 文献 · J Vasc Surg · 2025-01-10

单中心研究纳入2000年8月至2022年7月诊断的23例肱动脉真性动脉瘤患者,中位年龄50.4岁,78%为男性,65%有同侧动静脉瘘史。18例接受手术修复,术后2例出现并发症,中位随访2.4年时移植物通畅率为81%。作者认为有症状患者应推荐手术修复,无症状患者在存在腔内血栓且直径大于2.5 cm时可考虑手术。

要点

  • 肱动脉真性动脉瘤多见于男性,常与动静脉瘘史或结缔组织病相关。
  • 有症状患者推荐手术修复;无症状者伴腔内血栓且直径大于2.5 cm时可考虑手术。
  • 手术修复类型取决于动脉瘤长度和肱动脉冗余情况,中位随访2.4年通畅率81%。

核心结论

  • 肱动脉真性动脉瘤在男性及有动静脉瘘史或结缔组织病患者中更常见。
  • 作者认为所有有症状的真性肱动脉瘤患者应推荐手术修复。
  • 作者认为无症状患者若存在腔内血栓且直径大于2.5 cm,可考虑手术,并发症发生率低。
  • 修复类型取决于动脉瘤长度和肱动脉冗余情况,中位随访2.4年通畅率为81%。

研究设计与样本

  • 2000年8月至2022年7月在本医疗系统内诊断并治疗的真性肱动脉瘤患者的单中心研究,共23例。
  • 收集中位年龄50.4岁(范围1-75岁)、男性18例(78%)、平均体重指数25.8±6.5 kg/m2等人口学、影像和手术资料。

主要发现

  • 合并危险因素:高血压18例(79%)、吸烟史12例(52%)、高脂血症9例(39%)、冠心病5例(22%)。
  • 15例(65%)有同侧动静脉瘘史,12例(52%)有肾移植史,10例(44%)服用免疫抑制药物,4例(18%)有其他部位动脉瘤史,3例(13%)有结缔组织病。
  • 13例(57%)有局部或劳力性疼痛症状,10例(44%)无症状;平均动脉瘤直径2.9±2.0 cm。
  • 18例(78%)接受手术修复(13例有症状,5例无症状),其中反向大隐静脉8例(61.5%)、非反向大隐静脉3例(23.1%)、带环聚四氟乙烯人工血管1例(7.7%)、冷冻保存移植物1例(7.7%)。
  • 术后2例(11%)出现并发症(1例浅表伤口感染经抗生素治疗,1例血肿清除),无神经损伤或远端栓塞;中位随访2.4年(范围0.1-18.9年),5例失访,剩余13例移植物中10例(77%)保持通畅,3例无症状性移植物闭塞保守处理。

临床怎么用

  • 作者认为有症状的真性肱动脉瘤患者应推荐手术修复。
  • 作者认为无症状患者若存在腔内血栓且直径大于2.5 cm,可考虑手术,并发症发生率低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Brachial artery aneurysms are rare entities that have typically been associated with trauma, infection, arteriovenous fistula creation, or connective tissue disorders. These aneurysms are often asymptomatic, but they can also cause local tenderness or thrombo-embolic events. Due to the very low incidence of true brachial artery aneurysms, there are no standardized guidelines on their optimal management. METHODS: From August 2000 to July 2022, all patients with a diagnosis of true brachial artery aneurysm were managed within our health care system. Demographic information, imaging findings, and operative details for these patients were collected. RESULTS: Twenty-three patients with a diagnosis of true brachial artery aneurysm were identified. The median age was 50.4 years (range, 1-75 years). Eighteen patients (78%) were male, and the mean body mass index was 25.8 ± 6.5 kg/m2. Concomitant risk factors included hypertension in 18 (79%), a smoking history in 12 (52%), hyperlipidemia in nine (39%), and coronary artery disease in five (22%). Fifteen patients (65%) had a prior arterio-venous fistula created in the affected arm, 12 (52%) had a history of kidney transplant, and 10 (44%) were taking immunosuppressive medication. Four patients (18%) had a history of arterial aneurysm at other locations, and three (13%) had been diagnosed with a connective tissue disorder. Thirteen patients (57%) presented with symptoms of local or exertional pain, whereas 10 (44%) were asymptomatic. Ultrasound or computed tomography imaging was performed in all patients, with an average aneurysm size of 2.9 ± 2.0 cm. Eighteen patients (78%) underwent surgical repair (13 symptomatic and 5 asymptomatic). Surgical repair included resection of the aneurysm and brachio-brachial interposition/bypass graft placement with a reversed (n = 8; 61.5%) or non-reversed (n = 3; 23.1%) saphenous vein, ringed PTFE graft (n = 1; 7.7%), or cryopreserved graft (n = 1; 7.7%). Of the 18 patients who underwent surgical repair, two (11%) experienced a postoperative complication. One patient had a superficial wound infection managed with antibiotics, and the other patient underwent hematoma evacuation. There were no nerve injuries or distal embolization. At a median follow-up of 2.4 years (range, 0.1-18.9 years), five surgical patients were lost, and the remaining 10 of 13 grafts (77%) remained patent. Three patients developed asymptomatic graft occlusion, which were managed nonoperatively. Among the five asymptomatic patients who did not undergo aneurysm repair, two died awaiting transplant and another two were lost to follow-up. One patient's aneurysm thrombosed at 1-year follow-up without causing symptoms. CONCLUSIONS: Brachial artery aneurysm is diagnosed more commonly in male patients and in those who have a history of arteriovenous fistula creation or connective tissue disorder. Surgical repair of true brachial artery aneurysms should be recommended in all symptomatic patients. In asymptomatic patients, surgery was offered in the presence of aneurysms with intraluminal thrombus and diameter larger than 2.5 cm, with low morbidity. The type of repair is dictated by length of the aneurysm and presence of brachial artery redundancy, with patency of 81% at 2.4 years median follow-up.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zheng A, Sen I, De Martino R, et al. Presentation, treatment, and outcomes of brachial artery aneurysms. J Vasc Surg. 2025. PMID: 39800123. doi:10.1016/j.jvs.2025.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。